These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6187668)

  • 21. Structure of antigen-specific suppressor factors: current views.
    Kontiainen SK; James RF; Culbert EJ; Feldmann M
    Surv Immunol Res; 1982; 1(1):17-23. PubMed ID: 6195709
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification of mycobacterial peptide epitopes recognized by CD4+ T cells in association with multiple major histocompatibility complex class II molecules.
    Mustafa AS
    Nutrition; 1995; 11(5 Suppl):657-60. PubMed ID: 8748245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of streptococcal antigen-binding human T8+ cells and monocytes, in relation to the HLA-DRw6 locus and the helper, suppressor and contrasuppressor functions.
    Lehner T; Jones T
    Immunology; 1984 Oct; 53(2):215-25. PubMed ID: 6237980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-bound helper and suppressor factors in primate lymphocytes.
    Lehner T; Lamb JR; Kontiainen S
    Clin Exp Immunol; 1982 Mar; 47(3):706-14. PubMed ID: 6211310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function.
    Nutman TB; Ottesen EA; Fauci AS; Volkman DJ
    J Clin Invest; 1984 Jun; 73(6):1754-62. PubMed ID: 6233302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DA6-147 monoclonal antibody raised against the HLA-DR alpha chain identifies a cryptic epitope on the BoLA-DR alpha chain.
    Ababou A; Davis WC; Levy D
    Vet Res; 1993; 24(5):402-7. PubMed ID: 7505154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen-specific human T-cell factors: T-cell helper and suppressor factors, immunochemical aspects.
    Heijnen CJ; UytdeHaag F; Pot KH; Bentwich Z; Ballieux RE
    Ann Immunol (Paris); 1982; 133D(3):221-34. PubMed ID: 6187271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization against dental caries.
    Lehner T
    Vaccine; 1985 Mar; 3(1):65-8. PubMed ID: 3159164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of immunological parameters in kidney transplantation.
    Kreisler JM
    Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742
    [No Abstract]   [Full Text] [Related]  

  • 30. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
    Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
    Jansson R; Karlsson A; Forsum U
    Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens.
    Swain SL; Dialynas DP; Fitch FW; English M
    J Immunol; 1984 Mar; 132(3):1118-23. PubMed ID: 6198377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of antigen binding T cells separated by Vicia villosa or streptococcal antigen and the effect of HLA class II antigens.
    Lehner T; Jones T; Avery J
    Clin Exp Immunol; 1986 Feb; 63(2):312-20. PubMed ID: 2938853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
    Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
    Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific helper and suppressor T cell factors in man.
    Ballieux RE; Heijnen CJ
    Clin Haematol; 1982 Oct; 11(3):711-8. PubMed ID: 6217009
    [No Abstract]   [Full Text] [Related]  

  • 37. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically regulated human (T,G)-A-L specific helper T cell replacing factors possess HLA-DR and VH determinants.
    Katz D; Brautbar C; Bentwich Z; Mozes E
    Hum Immunol; 1983 Aug; 7(4):217-27. PubMed ID: 6193087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA serology--1983.
    Grumet FC
    Prog Clin Biol Res; 1984; 149():207-20. PubMed ID: 6204338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.